Hospira Inc. recalled Heparin Sodium Injection due to the presence of human hair particulates, according to the FDA on September 11, 2014. The agency announced the Class I recall under number D-0324-2015.
How to tell if you have it
- Brand: Hospira
- Product: HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL flexible container unit
- NDC: 0409-7620-03
- Lot #: 41-046-JT
- Expiration: 11/01/2015
The hazard
A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container. The FDA classified this as a Class I recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include the 2017-04-21 Hospira Infant Dextrose Injection Recall for hair particulates, the 2016-11-01 Hospira Fentanyl Injection Recall for broken ampule tips, and the 2016-08-15 Hospira DOBUTamine Injection Recall for discoloration and particulates. Other recent recalls of similar products include the 2026-07-16 Fresenius Kabi Lidocaine HCl Injection Recall and the 2026-07-16 Fresenius Kabi Xylocaine 1% Injection Recall for hair found in products, as well as the 2026-07-24 American Regent Nitroglycerin Injection Recall for particulate matter hazard.